Rocket


Overview
Financials
News + Filings

 
 

NUGENEREX IMMUNO-ONCOLOGY, INC. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsJul-31-19Jul-31-18
Revenues0.40.9
            Revenue growth-62.1% 
Cost of goods sold0.40.3
Gross profit0.00.7
            Gross margin-10.9%70.6%
General and administrative0.00.0
EBIT-0.40.4
            EBIT margin-110.9%45.5%
Pre-tax income-1.1-0.2
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-1.1-0.2
            Net margin-313.0%-18.5%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)400.0400.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy